Our Product

We at Syntr Health Technologies have developed a microfluidic processor, Syntrfuge™, for the enrichment and activation of adipose-derived stem cells for the treatment of difficult-to-treat wounds. Our point-of-care therapeutic allows for the rapid processing of a minimally manipulated autologous therapeutic for the treatment of difficult-to-treat wounds, such as diabetic foot ulcers.

  • Facebook - White Circle
  • Twitter - White Circle
  • LinkedIn - White Circle

© Syntr Health Technologies, INC. 2019 All Rights Reserved.